Company news
Mirum Pharmaceuticals, Inc. news in 2019
Mirum Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.
Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat
December 15, 2019
Mirum Pharmaceuticals Presents Data Demonstrating Long-term Durability of Treatment Effect of Maralixibat in Children With Cholestatic Liver Diseases
November 7, 2019
Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
November 5, 2019
Mirum Pharmaceuticals Announces Appointment of Ed Tucker as Chief Medical Officer
October 27, 2019
Mirum Pharmaceuticals to Present New Data at The Liver Meeting 2019
September 30, 2019
Mirum Pharmaceuticals Announces Pricing of Initial Public Offering
July 16, 2019